Work

Abstract 12579: Empagliflozin and the Risk of Atherosclerotic Events and Hospitalization for Heart Failure: Updated Analysis From the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

Year: 2021

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.144.suppl_1.12579

Authors: Phyo Htoo, Helen Tesfaye, Mehdi Najafzadeh, Sebastian Schneeweiss, Dureshahwar Jawaid, Deborah J Wexler, Robert Glynn, Lisette Koeneman, Anouk Deruaz Luyet, Julie Paik, Elisabetta Patorno

Institutions: Brigham and Women's Hospital, Harvard University, Massachusetts General Hospital, Boehringer Ingelheim (Germany)

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3214894998

Cites:

Cited by:

Related to: 10